Table 2.
Hematologic and organ response in the different study groups.
| Complete response (N = 161) N (%) | No complete response | ||||
|---|---|---|---|---|---|
| iFLC < 20 mg/L (N = 66) N (%) | Normal-iFLC (N = 114) N (%) | dFLC < 10 mg/L (N = 144) N (%) | Normal-FLCR (N = 220) N (%) | ||
| CR (N = 161) | 161 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| iFLC < 20 mg/L (N = 66) | 87 (54) | 66 (100) | 64 (97) | 57 (86) | 46 (70) |
| Normal-iFLC (N = 114) | 86 (53) | 64 (56) | 114 (100) | 86 (75) | 81 (71) |
| dFLC < 10 mg/L (N = 144) | 103 (64) | 57 (39) | 86 (60) | 144 (100) | 104 (72) |
| Normal-FLCR (N = 220) | 161 (100) | 46 (70) | 81 (71) | 104 (72) | 220 (100) |
| IFE serum and urine negative | 161 (100) | 4 (6) | 4 (3) | 3 (2) | 0 (0) |
Numbers in parenthesis represent the percentage of the patients of the referred row in all cases with the exception of the last row in which those numbers refer to the single column.
CR complete response, iFLC involved free light chains, dFLC difference between involved and uninvolved free light chains, IFE immunofixation.
Bold values represent row/column match.